Clinical and observational studies of Normacor® at leading cardiac surgery centers in Russia demonstrate the efficacy and safety of normothermic blood cardioplegia, supported by real-world data
Evidence base
Clinical experience

Clinical trials

Registration and post-registration clinical trials of the drug Normacor®, including those approved by the Ministry of Health of the Russian Federation

    Original research in specialized healthcare institutions of the Russian Federation

    Experience of leading cardiac surgery centers in Russia: comparative and observational studies of the use of Normacor in real-life clinical practice
      JSC "CARDIOSYSTEMPHARMA"
      Owner LP-No.(015032)-(RG-RU)
      2a-1, Rabochaya, St. Khimki, Moscow Region, 141401 Russia
      OUR SOCIAL MEDIA
      Contacts
      Russian Verision
      Мы используем куки для работы сайта
      Ок, закрыть